Publications and communications of Rahmouni, Souad

International IBD Genetics Consortium, Rahmouni, S., Georges, M., & LOUIS, E. (In press). Sequencing of over 100,000 individuals identifies multiple genes and rare variants associated with Crohns disease susceptibility. Nature Genetics. doi:10.1101/2021.06.15.21258641

Petrov, V., Sharapov, S., Shagam, L., Nostaeva, A., Pezer, M., Li, D., Hanić, M., McGovern, D., LOUIS, E., Rahmouni, S., Lauc, G., Georges, M., & Aulchenko, Y. S. (In press). Association between human gut microbiome and N-glycan composition of total plasma proteome. Frontiers in Microbiology.

Desmecht, S., Tashkeev, A., Nicole Marechal, N., Perée, H., Tokunaga, Y., Fombellida-Lopez, C., Polese, B., Legrand, C., Wéry, M., Mni, M., Fouillien, N., TOUSSAINT, F., Gillet, L., Bureau, F., LUTTERI, L., HAYETTE, M.-P., MOUTSCHEN, M., MEURIS, C., Desmecht, D., & DARCIS, G. (2022). Kinetics and persistence of the cellular and humoral immune responses to BNT162b2 mRNA vaccine in SARS-CoV-2-naive and -experienced subjects. Eprint/Working paper retrieved from https://orbi.uliege.be/2268/267394. doi:10.1101/2022.01.17.22269278

Khbouz, B., Rowart, P., POMA, L., Dahlke, E., Bottner, M., Matt, S., Bolen, G., Rahmouni, S., Theilig, F., & JOURET, F. (2021). The genetic deletion of the Dual Specificity Phosphatase 3 (DUSP3) attenuates kidney damage following ischemia/reperfusion injury in mouse. Acta Physiologica. doi:10.1111/apha.13735

Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Nafría-Jiménez, B., Bouysran, Y., Niemi, M., Palom, A., Ellinghaus, D., Khan, A., Martínez-Bueno, M., Rolker, S., Amitano, S., Tato, L. R., Fava, F., Spinner, C. D., Prati, D., & consortium, C.-H. (October 2021). Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Journal of Clinical Investigation, Online ahead of print.. doi:10.1172/JCI152386

Khbouz, B., Rowart, P., POMA, L., Bottner, M., Bolen, G., Rahmouni, S., Theilig, F., & JOURET, F. (31 August 2021). Role of the Dual Specificity Phosphatase 3 (DUSP3) in renal ischemia/reperfusion injury. Paper presented at The European Society for Organ Transplantation 2021, Milan, Italy.

Khbouz, B., Rowart, P., POMA, L., Bottner, M., Bolen, G., Rahmouni, S., Theilig, F., & JOURET, F. (05 June 2021). The genetic deletion of the Dual Specificity Phosphatase 3 (DUSP3) attenuates kidney damage following ischemia/reperfusion injury in mouse. Paper presented at 58ème congrès de "The European Renal Association – European Dialysis and Transplant Association", Berlin, Germany.

Latour, S., Shagam, L., Mariman, R., Momozawa, Y., Louis, E., Rahmouni, S., & Georges, M. (June 2021). Identification of novel loci associated with human microbiota composition. Poster session presented at International Human Microbiome Consortium Congress 2021.

Perée, H., Mayer, A., Takeda, H., Karim, L., Deckers, M., Jacques, S., Mni, M., Wéry, M., Azarzar, S., Tokunaga, Y., Coppieters, W., Georges, M., & Rahmouni, S. (May 2021). Comparative analysis of ultra low input RNA sequencing methods for the study of rare immune cell populations. Poster session presented at 33rd meeting on The Biology of Genomes.

Defêche, J., AZARZAR, S., Mesdagh, A., DELLOT, P., Tytgat, A., Bureau, F., Gillet, L., Belhadj, Y., BONTEMS, S., HAYETTE, M.-P., Schils, R., Rahmouni, S., ERNST, M., MOUTSCHEN, M., & DARCIS, G. (2021). In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2. Pathogens (Basel, Switzerland), 10 (11). doi:10.3390/pathogens10111362

Jacques, S., Arjomand, A., Perée, H., COLLINS, P., Mayer, A., Lavergne, A., Wéry, M., Mni, M., Hego, A., Thuillier, V., Becker, G., Bahri, M. A., Plenevaux, A., Di Valentin, E., Oury, C., MOUTSCHEN, M., Delvenne, P., Paquot, N., & Rahmouni, S. (2021). Dual‑specificity phosphatase 3 deletion promotes obesity, non‑alcoholic steatohepatitis and hepatocellular carcinoma. Scientific Reports, 11, 5817. doi:10.1038/s41598-021-85089-6

Lieferinckx, C., De Grève, Z., Toubeau, J. F., Perée, H., Quertinmont, E., Tafciu, V., Minsart, C., Rahmouni, S., Georges, M., Vallée, F., & Franchimont, D. (2021). New approach to determine the healthy immune variations by combining clustering methods. Scientific Reports, 11, 8917. doi:10.1038/s41598-021-88272-x

Scherer, M., Gasparoni, G., Rahmouni, S., Shashkova, T., Arnoux, M., Louis, E., Nostaeva, A., Avalos, D., Dermitzakis, E. T., Aulchenko, Y. S., Lengauer, T., Lyons, P. A., Georges, M., & Walter, J. R. (2021). Identification of tissue-specific and common methylation quantitative trait loci in healthy individuals using MAGAR. Epigenetics and Chromatin, 14 (1), 44. doi:10.1186/s13072-021-00415-6

The COVID-19 Host Genetics Initiative, Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., & HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x

Bonaguro, L., Köhne, M., Schmidleithner, J., Warnat-Herresthal, S., Horne, A., Kern, P., Günther, P., Ter Horst, R., Jaeger, M., Rahmouni, S., Georges, M., Falk, C. S., Li, Y., Mass, E., Beyer, M., Joosten, L. A. B., Netea, M. G., Ulas, T., Schultze, J. L., & Aschenbrenner, A. C. (21 December 2020). CRELD1 modulates homeostasis of the immune system in mice and humans. Nature Immunology, 12, 1517-1527. doi:10.1038/s41590-020-00811-2

Jacques, S., Vandereyken, M., Arjomand, A., Rahmouni, S., & Oury, C. (21 January 2019). DUSP3 genetic depletion predispose to obesity-induced hepatocellular carcinoma. Poster session presented at Integrated pathways of disease in NASH and NAFLD, Santa Fe, United States.

Weersma, R., Barrett, J., Vermeire, S., Xavier, R., Anderson, C., Wijmenga, C., Daly, M., Alm, E., Raes, J., Huttenhower, C., Stappenbeck, T., Netea, M., Kaser, A., Franke, A., McGovern, D., Colombel, J., van den Brink, G., Uhlig, H., Georges, M., & Moutsianas, L. (November 2018). Multiomics Analyses to Deliver the Most Effective Treatment to Every Patient With Inflammatory Bowel Disease. Gastroenterology, 155 (5), 1-e4. doi:10.1053/j.gastro.2018.07.039

Rowart, P., POMA, L., Rahmouni, S., KRZESINSKI, J.-M., & JOURET, F. (25 May 2018). Genetic deletion of DUSP3 phosphatase attenuates kidney damage and inflammation following ischemia/reperfusion in mouse. Poster session presented at 55th ERA-EDTA, Copenhague, Denmark.

Rowart, P., POMA, L., Rahmouni, S., KRZESINSKI, J.-M., & JOURET, F. (20 April 2018). Genetic deletion of DUSP3 phosphatase attenuates kidney damage and inflammation following ischemia/reperfusion in mouse. Paper presented at 4th International Meeting on Ischemia Reperfusion Injury in Transplantation (IMIRT), Poitiers, France.

Rowart, P., POMA, L., Rahmouni, S., KRZESINSKI, J.-M., & JOURET, F. (16 March 2018). Genetic deletion of DUSP3 phosphatase attenuates kidney damage and inflammation following ischemia/reperfusion in mouse. Paper presented at Belgian Transplant Society - COMBINED NTV & BTS ANNUAL MEETING 2018, Rotterdam, Netherlands.

Servais, L., Wéra, O., Dibato Epoh, J., Delierneux, C., Bouznad, N., Rahmouni, S., Mazzucchelli, G., Baiwir, D., Delvenne, P., LANCELLOTTI, P., & Oury, C. (2018). Platelets contribute to the initiation of colitis-associated cancer by promoting immunosuppression. Journal of Thrombosis and Haemostasis. doi:10.1111/jth.13959

Yukihide, M., Dmitrieva, J. B., Theatre, E., Deffontaine, V., Rahmouni, S., Charloteaux, B., Crins, F., Elansary, M., Gori, A.-S., LECUT, C., Mariman, R., Mni, M., Oury, C., Altukhov, I., Alexeev, D., Aulchenko, Y., Amininejad, L., van der Meulen-de Jong, A. E., van der Woude, C. J., & Georges, M. (2018). IBD risk loci are enriched in multigenic regulatory modules encompassing causative genes. Nature Communications. doi:10.1038/s41467-018-04365-8

Vandereyken, M., Jacques, S., Van Overmeire, E., Amand, M., Rocks, N., Delierneux, C., Singh, P., Singh, M., GHUYSEN, C., Wathieu, C., Zurashvili, T., Sounni, N. E., Moutschen, M., Gilles, C., Oury, C., Cataldo, D., Van Ginderachter, J. A., & Rahmouni, S. (2017). Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner. PLoS ONE. doi:10.1371/journal.pone.0185786

Jacques, S., Arjomand, A., Vandereyken, M., Oury, C., & Rahmouni, S. (24 July 2017). Dual-specificity-phosphatase 3 (DUSP3) deletion promotes liver inflammation and high fat diet-induced hepatocellular carcinoma. Poster session presented at Sophie Jacques, Paris, France.

Delierneux, C., Donis, N., Servais, L., Wéra, O., LECUT, C., Vandereyken, M., Musumeci, L., Rahmouni, S., Schneider, J., Eble, J., LANCELLOTTI, P., & Oury, C. (May 2017). Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides. Journal of Thrombosis and Haemostasis, 15 (5), 983-997. doi:10.1111/jth.13669

Vandereyken, M., Singh, P., Wathieu, C., Jacques, S., Zurashvili, T., Dejager, L., Amand, M., Musumeci, L., Singh, M., MOUTSCHEN, M., Libert, C., & Rahmouni, S. (2017). Dual-Specificity Phosphatase Deletion Protects Female, but Not Male, Mice from Endotoxemia- and Polymicrobial-Induced Septic Shock. Journal of Immunology. doi:10.4049/jimmunol.1602092

Jacques, S., Arjomand, A., Vandereyken, M., Moutschen, M., Oury, C., & Rahmouni, S. (08 December 2016). DUSP3 genetic deletion predispose to obesity-induced hepatocellular carcinoma. Poster session presented at Séminaire des chercheurs Télévie, Louvain, Belgium.

Amand, M., ERPICUM, C., Gilles, C., Noël, A., & Rahmouni, S. (2016). Functional analysis of dual-specificity protein phosphatases in angiogenesis. In R. Pulido (Ed.), Protein Tyrosine Phosphatases: Methods and Protocols (pp. 331-49). New York, United States: Springer Science. doi:10.1007/978-1-4939-3746-2_18

Rahmouni, S., Hego, A., Delierneux, C., Wéra, O., Musumeci, L., Tautz, L., & Oury, C. (2016). Functional analysis of protein tyrosine phosphatases in thrombosis and haemostasis. In Protein Tyrosine Phosphatases: Methods and Protocols (pp. 301-30). New York, United States: Springer Science.

Göktuna, S., Shostak, K., Chau, T.-L., Heukamp, L., Hennuy, B., Duong, H. Q., LADANG, A., Close, P., Klevernic, I., Olivier, F., Florin, A., Ehx, G., Baron, F., Vandereyken, M., Rahmouni, S., Vereecke, L., van Loo, G., Büttner, R., Greten, F., & Chariot, A. (2016). The Prosurvival IKK-Related Kinase IKK« Integrates LPS and IL17A Signaling Cascades to Promote Wnt-Dependent Tumor Development in the Intestine. Cancer Research, 76, 2587-99. doi:10.1158/0008-5472.CAN-15-1473

Tautz, L., Rahmouni, S., Oury, C., & Musumeci, L. (27 June 2015). DUSP3 Phosphatase Deficiency or Inhibition Limits Platelet Activation and Arterial Thrombosis. Paper presented at Europhosphatase 2015: Phosphorylation switches and cellular homeostasis, Turku, Finland.

Rahmouni, S., MUSUMECI, L., Kuijpers, M. J., Gilio, K., Hego, A., Theatre, E., Senis, Y., Heemskerk, J., Thiry, M., Tautz, L., & Oury, C. (24 June 2015). DUSP3 Phosphatase Deficiency or Inhibition Limits Platelet Activation and Arterial Thrombosis. Paper presented at ISTH 2015 Congress, Toronto, Canada.

Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., MUSUMECI, L., Rahmouni, S., BOURS, V., LANCELLOTTI, P., & Oury, C. (22 June 2015). CLEC-2 is required for the activation of mouseplatelets by bacterial DNA mimetics. Paper presented at ISTH 2015 Congress, Toronto, Canada.

Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., MUSUMECI, L., Rahmouni, S., BOURS, V., Lancellotti, P., & Oury, C. (22 June 2015). CLEC-2 is required for the activation of mouse platelets by bacterial DNA mimetics. Paper presented at ISTH 2015 Congress, Toronto, Canada.

Tautz, L., Senis, Y., Oury, C., & Rahmouni, S. (15 June 2015). Perspective: Tyrosine Phosphatases As Novel Targets For Antiplatelet Therapy. Bioorganic and Medicinal Chemistry, 23 (12), 2786-97. doi:10.1016/j.bmc.2015.03.075

Vandereyken, M., Amand, M., Van Overmeire, E., Zurashvili, T., MOUTSCHEN, M., Gilles, C., Van Ginderachter, J., & Rahmouni, S. (June 2015). Genetic depletion of the dual specificity protein phosphatase DUSP3 promotes LLC Lung tumour metastasis. Paper presented at Europhosphatase 2015: Phosphorylation switches and cellular homeostasis, Turku, Finland.

Vandereyken, M., Amand, M., Van Overmeire, E., Zurashvili, T., MOUTSCHEN, M., Noël, A., Gilles, C., Van Ginderachter, J., & Rahmouni, S. (June 2015). Genetic depletion of the dual specificity protein phosphatase DUSP3 promotes LLC Lung tumour metastasis. Poster session presented at Europhosphatase 2015: Phosphorylation switches and cellular homeostasis, Turku, Finland.

Singh, P.* , Dejager, L.* , Amand, M.* , Theatre, E., Vandereyken, M., Zurashvili, T., Singh, M., Mack, M., Timmermans, S., Musumeci, L., Dejardin, E., Mustelin, T., Van Ginderachter, J. A., Moutschen, M., Oury, C., Libert, C., & Rahmouni, S. (15 May 2015). DUSP3 genetic deletion confers M2-like−macrophage-dependent tolerance to septic shock. Journal of Immunology, 194 (10), 4951-62. doi:10.4049/jimmunol.1402431

Musumeci, L., Kuijpers, M., Gilio, K., Hego, A., Theatre, E., Maurissen, L., Vandereyken, M., Diogo, C., LECUT, C., Guilmain, W., Bobkova, E., Eble, J., Dahl, R., Drion, P., Rascon, J., Mostofi, Y., Yuan, H., Sergienko, E., Chung, T., & Rahmouni, S.*. (17 February 2015). DUSP3 Phosphatase Deficiency or Inhibition Limit Platelet Activation and Arterial Thrombosis. Circulation, 131 (7), 656-68. doi:10.1161/CIRCULATIONAHA.114.010186

Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., Musumeci, L., Rahmouni, S., Thiry, M., Compère, P., BOURS, V., Lancellotti, P., & Oury, C. (27 January 2015). Bacterial DNA mimetics activate platelets and promote thrombosis via CLEC-2. Poster session presented at GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium.

Oury, C., Rahmouni, S., & LANCELLOTTI, P. (2015). Les antiplaquettaires : quoi de neuf ? MS. Medecine Sciences. doi:10.1051/medsci/20153108006

Singh, M., Singh, P., VAIRA, D., Torheim, E. A., Rahmouni, S., Tasken, K., & MOUTSCHEN, M. (February 2014). The RIAD peptidomimetic inhibits HIV-1 replication in humanized NSG mice. European Journal of Clinical Investigation, 44 (2), 146-152. doi:10.1111/eci.12200

Amand, M., Erpicum, C., BAJOU, K., Cerignoli, F., Blacher, S., MARTIN, M., Dequiedt, F., Drion, P., Singh, P., Vandereyken, M., Musumeci, L., Moutschen, M., Gilles, C., Noël, A., & Rahmouni, S. (27 January 2014). DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase. Poster session presented at GIGA Day 2014, Liège, Belgium. doi:10.1186/1476-4598-13-108

Amand, M., Erpicum, C., BAJOU, K., Cerignoli, F., Blacher, S., Martin, M., Dequiedt, F., Drion, P., Singh, P., Zurashvili, T., Vandereyken, M., Musumeci, L., Mustelin, T., Moutschen, M., Gilles, C., Noël, A., & Rahmouni, S. (2014). DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase. Molecular Cancer. doi:10.1186/1476-4598-13-108

Singh, M., Singh, P., VAIRA, D., Amand, M., Rahmouni, S., & Moutschen, M. (2014). Minocycline attenuates HIV-1 infection and suppresses chronic immune activation in humanized NOD/LtsZ-scidIL-2Rgamma(null) mice. Immunology, 142 (4), 562-72. doi:10.1111/imm.12246

Musumeci, L., Maurissen, L., Kuijpers, M. J., Senis, Y., MOUTSCHEN, M., Mustelin, T., Heemskerk, J. W., Oury, C., & Rahmouni, S. (02 July 2013). Genetic deletion of Vaccinia H1-related (VHR) phosphatase inhibits collagen-induced platelet activation and thrombus formation without affecting bleeding time in mice. Paper presented at XXIVth Congress of the ISTH, Amsterdam, Netherlands.

Rahmouni, S., Singh, P., Dejager, L., Singh, M., Amand, M., Musumeci, L., Moutschen, M., Mustelin, T., & Libert, C. (2013). Dual-specificity phosphatase 3 knockout female mice are resistant to LPS and to polymicrobial induced septic shock in TNF dependent manner. Journal of Immunology.

Bruck, F.* , Belle, L.* , LECHANTEUR, C., de Leval, L., Hannon, M., DUBOIS, S., CASTERMANS, E., Humblet-Baron, S., Rahmouni, S., Beguin, Y., BRIQUET, A.* , & Baron, F.*. (March 2013). Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease. Cytotherapy, 15 (3), 267-279. doi:10.1016/j.jcyt.2012.09.003

Rahmouni, S., Delacroix, L., Liu, W., & Tautz, L. (2013). Evaluating Effects of Tyrosine Phosphatase Inhibitors on T Cell Receptor Signaling. In Phosphatase Modulators, Methods in Molecular Biology. Springer Science. doi:10.1007/978-1-62703-562-0_15

Tautz, L., Vang, T., Liu, W., Delacroix, L., Wu, S., Vasile, S., Dahl, R., Yang, L., MUSUMECI, L., Francis, D., Landskron, J., Tasken, K., Tremblay, M., Lie, B., Page, R., Mustelin, T., Rahmouni, S., & Rickert, R. (April 2012). Dynamic interaction between lymphoid tyrosine phosphatase and C-terminal Src kinase controls T cell activation. FASEB Journal, 26.

Bruck, F., de Leval, L., Belle, L., LECHANTEUR, C., Hannon, M., BRIQUET, A., Dubois, S., CASTERMANS, E., Humblet-Baron, S., Rahmouni, S., BEGUIN, Y., & BARON, F. (2012). Bone marrow-derived mesenchymal stromal cells failed to prevent experimental xenogeneic graft-versus-host disease. Poster session presented at Belgian Hematological Society General Annual Meeting.

Singh, M., Singh, P., Gaudray, G., Musumeci, L., Thielen, C., VAIRA, D., Vandergeeten, C., Delacroix, L., Van Gulck, E., Vanham, G., de Leval, L., Rahmouni, S., & MOUTSCHEN, M. (2012). An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rgammanull mice allows HIV replication and development of anti-HIV immune responses. PLoS ONE, 7 (6), 38491. doi:10.1371/journal.pone.0038491

Vang, Liu, W. H., Delacroix, L., Wu, S., Vasile, S., Dahl, R., Yang, L., Musumeci, L., Francis, D., Landskron, J., Tasken, T., Tremblay, M. L., Lie, B. A., Page, R., Mustelin, T., Rahmouni, S., Rickert, R. C., & Tautz, L. (2012). LYP inhibits T-cell activation when dissociated from CSK. Nature Chemical Biology. doi:10.1038/nchembio.916

Singh, M., Singh, P., VAIRA, D., Tasken, K., Rahmouni, S., & Moutschen, M. (03 October 2011). Humanized mice as a useful model to study HIV-1 induced immune activation, its mechanisms and potential therapeutic approaches. Retrovirology, 8, 62.

Mosenden, R.* , Singh, P.* , Cornez, I., Heglind, M., Ruppelt, A., MOUTSCHEN, M., Enerbäck, S., Rahmouni, S., & Tasken, K. (2011). Mice with Disrupted Type I Protein Kinase A Anchoring in T Cells Resist Retrovirus-Induced Immunodeficiency. Journal of Immunology, 186 (9), 5119-30. doi:10.4049/jimmunol.1100003

Charlier, E., Condé, C., Zhang, J., Deneubourg, L., Di Valentin, E., Rahmouni, S., Chariot, A., Agostinis, P., Pang, P.-C., Haslam, S., Dell, A., Penninger, J., Erneux, C., Piette, J., & Gloire, G. (2010). SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity. Leukemia. doi:10.1038/leu.2010.9

Geenen, V., Mottet, M., Dardenne, O., Kermani, H., Martens, H., François, J.-M., Galleni, M., Hober, D., Rahmouni, S., & Moutschen, M. (2010). Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes. Current Opinion in Pharmacology, 10, 461-472. doi:10.1016/j.coph.2010.04.005

Wu, S.* , Vossius, S.* , Rahmouni, S.* , Miletic, A. V., Vang, T., Vazquez-Rodriguez, J., Cerignoli, F., Arimura, Y., Williams, S., Hayes, T., Moutschen, M., Vasile, S., Pellecchia, M., Mustelin, T., & Tautz, L. (12 November 2009). Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells. Journal of Medicinal Chemistry, 52 (21), 6716-23. doi:10.1021/jm901016k

Creppe, C., Malinouskaya, L., Volvert, M.-L., Gillard, M., Close, P., Malaise, O., Laguesse, S., Cornez, I., Rahmouni, S., Ormenese, S., Belachew, S., Malgrange, B., Chapelle, J.-P., Siebenlist, U., Moonen, G., Chariot, A., & Nguyen, L. (06 February 2009). Elongator controls the migration and differentiation of cortical neurons through acetylation of a tubulin. Cell, 136, 551-564. doi:10.1016/j.cell.2008.11.043

Tautz, L., Mustelin, T., Wu, S., Vossius, S., Rahmouni, S., Vasile, S., Sergienko, E., Stonich, D., Yuan, H., Su, H., Dahl, Y., Mostofi, Y., & Chung, T. D. (2009). Small-Molecule Inhibitors of Vaccinia-H1-Related Phosphatase VHR. Bethesda, United States: National Center for Biotechnology Information (US).

Bayón, Y., Trinidad, A. G., de la Puerta, M. L., del Carmen Rodríguez, M., Bogetz, J., Rojas, A., De Pereda, J., Rahmouni, S., Williams, S., Matsuzawa, S.-I., Reed, J. C., Sánchez Crespo, M., Mustelin, T., & Alonso, A. (28 July 2008). KCTD5, a putative substrate adaptor for cullin3 ubiquitin ligases. FEBS Journal, 275 (15), 3900 - 3910. doi:10.1111/j.1742-4658.2008.06537.x

Henkens, R., Delvenne, P., Arafa, M., Moutschen, M., Zeddou, M., Tautz, L., Boniver, J., Mustelin, T., & Rahmouni, S. (2008). Cervix carcinoma is associated with an up-regulation and nuclear localization of the dual-specificity protein phosphatase VHR. BMC Cancer, 8, 147. doi:10.1186/1471-2407-8-147

Nayjib, B., Zeddou, M., Drion, P., Boniver, J., Tasken, K., Rahmouni, S., & Moutschen, M. (2008). In vivo administration of a PKA type I inhibitor (Rp-8-Br-cAMPS) restores T-cell responses in retrovirus-infected mice. Open Immunology Journal, 1, 20-24. doi:10.2174/1874226200801010020

Renoux, V., Dortu, E., Herman, L., Rahmouni, S., Boniver, J., Delvenne, P., & Jacobs, N. (01 June 2007). NK Cells Interact With virus–like particles (VLP) of human papillomavirus (HPV). Paper presented at Journées du Centre de recherche en cancérologie expérimentale (CRCE), Liege, Belgium.

Creppe, C., Close, P., Cornez, I., Rahmouni, S., Merville, M.-P., Chapelle, J.-P., Nusgens, C., Deroanne, C., & Chariot, A. (March 2007). A role for the transcriptional complex elongator in cell migration and spreading. Poster session presented at Colloque "Chromatin Dynamics and Epigenetics" Société belge de biologie cellulaire et du développement, Liège, Belgium.

Springael, C., Thomas, S., Rahmouni, S., Vandamme, A., Goldman, M., Willems, F., & Vosters, O. (15 February 2007). Rottlerin inhibits human T cell responses. Biochemical Pharmacology, 73 (4), 515-525. doi:10.1016/j.bcp.2006.10.034

Chandrika, K., Dellot, P., Frippiat, F., Giot, J.-B., Leonard, P., Marée, R., Mayasi, N., Meuris, C., Mukeba Tshialala, D., Rahmouni, S., Uurlings, F., Vaira, D., Wehenkel, L., Demonty, J., & Moutschen, M. (2007). Nouvelles approches dans la prise en charge de l'infection a VIH. Revue Médicale de Liège, 62 Spec No, 47-50.

Zeddou, M., Rahmouni, S., Vandamme, A., Jacobs, N., Frippiat, F., Leonard, P., SCHAAF-LAFONTAINE, N., Vaira, D., Boniver, J., & Moutschen, M. (2007). Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts. Retrovirology, 4, 72. doi:10.1186/1742-4690-4-72

Rahmouni, S., Cerignoli, F., Alonso, A., Tsutji, T., Henkens, R., Zhu, C., Louis-dit-Sully, C., Moutschen, M., Jiang, W., & Mustelin, T. (May 2006). Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence. Nature Cell Biology, 8 (5), 524-U178. doi:10.1038/ncb1398

Zeddou, M., Boniver, J., Moutschen, M., & Rahmouni, S. (February 2006). Prostanglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway. Paper presented at Keystone Symposia - Innate Immunity, Banff, Canada.

Cerignoli, F., Rahmouni, S., Ronai, Z. E., & Mustelin, T. (2006). Regulation of MAP kinases by the VHR dual-specific phosphatase: implications for cell growth and differentiation. Cell Cycle, 5 (19), 2210-5. doi:10.4161/cc.5.19.3267

Gloire, G., Charlier, E., Rahmouni, S., Volanti, C., Chariot, A., Erneux, C., & Piette, J. (2006). Restoration of SHIP-1 activity in human leukemic cells modifies NF-kappaB activation pathway and cellular survival upon oxidative stress. Oncogene, 25 (40), 5485-94. doi:10.1038/sj.onc.1209542

Nika, K., Charvet, C., Williams, S., Tautz, L., Bruckner, S., Rahmouni, S., Bottini, N., Schoenberger, S. P., Baier, G., Altman, A., & Mustelin, T. (2006). Lipid raft targeting of hematopoietic protein tyrosine phosphatase by protein kinase C theta-mediated phosphorylation. Molecular and Cellular Biology, 26 (5), 1806-16. doi:10.1128/MCB.26.5.1806-1816.2006

Zeddou, M., Rahmouni, S., VANDAMME, A., Schaaf-Lafontaine, N., & Moutschen, M. (2006). HIV viraemic patients downregulate CD94/NKG2A inhibitory receptors on NK as well as CD8 T cells in comparison with aviraemic counterparts. Poster session presented at AIDS 2006 - XVI International AIDS Conference.

Rahmouni, S., Vang, T., Alonso, A., Williams, S., van Stipdonk, M., Soncini, C., Moutschen, M., Schoenberger, S. P., & Mustelin, T. (March 2005). Removal of C-terminal Src kinase from the immune synapse by a new binding protein. Molecular and Cellular Biology, 25 (6), 2227-2241. doi:10.1128/MCB.25.6.2227-2241.2005

Bruckner, S., Rahmouni, S., Tautz, L., Denault, J.-B., Alonso, A., Becattini, B., Salvesen, G. S., & Mustelin, T. (2005). Yersinia phosphatase induces mitochondrially dependent apoptosis of T cells. Journal of Biological Chemistry, 280 (11), 10388-94. doi:10.1074/jbc.M408829200

Havard, L., Rahmouni, S., Boniver, J., & Delvenne, P. (2005). High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins. Virology, 331 (2), 357-66. doi:10.1016/j.virol.2004.10.030

Zeddou, M., Greimers, R., de Valensart, N., Nayjib, B., Tasken, K., Boniver, J., Moutschen, M., & Rahmouni, S. (2005). Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway. Biochemical Pharmacology, 70 (5), 714-24. doi:10.1016/j.bcp.2005.05.015

Rahmouni, S., Aandahl, E. M., Nayjib, B., Zeddou, M., Giannini, S., Verlaet, M., Greimers, R., Boniver, J., Tasken, K., & Moutschen, M. (15 December 2004). Cyclo-oxygenase type 2-dependent prostaglandin E-2 secretion is involved in retrovirus-induced T-cell dysfunction in mice. Biochemical Journal, 384 (Pt 3), 469-476. doi:10.1042/BJ20031859

tasken, K., MOUTSCHEN, M., Rahmouni, S., Aandahl, E. M., Aukurst, P., Froland, S., Johansson, C., Hansson, V., & Klaveness, J. (29 April 2004). Use of COX-2 inhibitors for preventing immunodeficiency.

Alonso, A., Bottini, N., Bruckner, S., Rahmouni, S., Williams, S., Schoenberger, S. P., & Mustelin, T. (2004). Lck dephosphorylation at Tyr-394 and inhibition of T cell antigen receptor signaling by Yersinia phosphatase YopH. Journal of Biological Chemistry, 279 (6), 4922-8. doi:10.1074/jbc.M308978200

Bottini, N., Musumeci, L., Alonso, A., Rahmouni, S., Nika, K., Rostamkhani, M., MacMurray, J., Meloni, G. F., Lucarelli, P., Pellecchia, M., Eisenbarth, G. S., Comings, D., & Mustelin, T. (2004). A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nature Genetics, 36 (4), 337-8. doi:10.1038/ng1323

Mustelin, T., Alonso, A., Bottini, N., Huynh, H., Rahmouni, S., Nika, K., Louis-dit-Sully, C., Tautz, L., Togo, S. H., Bruckner, S., Mena-Duran, A. V., & al-Khouri, A. M. (2004). Protein tyrosine phosphatases in T cell physiology. Molecular Immunology, 41 (6-7), 687-700. doi:10.1016/j.molimm.2004.04.015

Mustelin, T., Rahmouni, S., Alonso, A., Williams, S., Van Stipdonk, M., Soncini, C., & Schoenberger, S. (2004). Removal of C-terminal Src kinase from the immune synapse by a new binding protein. Cancer Research, 45.

Alonso, A., Rahmouni, S., Williams, S., van Stipdonk, M., Jaroszewski, L., Godzik, A., Abraham, R. T., Schoenberger, S. P., & Mustelin, T. (2003). Tyrosine phosphorylation of VHR phosphatase by ZAP-70. Nature Immunology, 4 (1), 44-8. doi:10.1038/ni856

Mustelin, T., Rahmouni, S., Bottini, N., & Alonso, A. (2003). Role of protein tyrosine phosphatases in T cell activation. Immunological Reviews, 191, 139-47. doi:10.1034/j.1600-065X.2003.00014.x

Verlaet, M., Duyckaerts, C., Rahmouni, S., Denis, G., Humblet, C., Greimers, R., Sluse, F., Boniver, J., & Defresne, M.-P. (01 July 2002). Transient modifications of respiratory capacity in thymic cells during murine radioleukemogenesis. Free Radical Biology and Medicine, 33 (1), 76-82. doi:10.1016/S0891-5849(02)00858-4

TASKÉN, K., Moutschen, M., Rahmouni, S., Aandahl, E. M., AUKRUST, P., FRØLAND, S. S., JOHANSSON, C. C., HANSSON, V., & KLAVENESS, J. (31 January 2002). USE OF COX-2 INHIBITORS FOR PREVENTING IMMUNODEFICIENCY.

Rahmouni, S. (2001). Rôle des prostanoïdes et de l'AMP cyclique dans les anomalies fonctionnelles lymphocytaires associées au MAIDS, syndrome murin d'immunodéficience acquise. Unpublished doctoral thesis, ULiège - Université de Liège.
Jury: Boniver, J. (Promotor), & Moutschen, M. (Promotor).

Rahmouni, S., Aandahl, E. M., Trebak, M., Boniver, J., Tasken, K., & Moutschen, M. (2001). Increased Camp Levels and Protein Kinase (Pka) Type I Activation in Cd4+ T Cells and B Cells Contribute to Retrovirus-Induced Immunodeficiency of Mice (Maids): A Useful in Vivo Model for Drug Testing. FASEB Journal, 15 (8), 1466-1468. doi:10.1096/fj.00-0813fje

Trebak, M., Lambert, C. A., Rahmouni, S., Debrus, S., Defresne, M.-P., Regnier, D., Boniver, J., & Moutschen, M. (15 September 1998). Decreased Protein Levels of the C-Cbl Protooncogene in Murine Aids. Cellular Immunology, 188 (2), 151-7. doi:10.1006/cimm.1998.1348

Trebak, M., Lambert, C., Rahmouni, S., Greimers, R., Boniver, J., & Moutschen, M. (1998). Reciprocal regulation of protein tyrosine kinases p56lck and p59fyn, and altered tyrosine phosphorylation in murine AIDS. International Immunology, 10 (10), 1473-80. doi:10.1093/intimm/10.10.1473

Rahmouni, S. (1994). Modelisation du cycle d'azote du microplancton dans la mer du nord. Unpublished DEA/DES thesis, ULiège - Université de Liège.
Jury: Nihoul, J. (Promotor).